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To evaluate the role of lipid charge density in the serum stability of DOTAP-Chol/DNA complexes (lipoplexes), lipid–DNA interactions,
extent of aggregation, supercoil content, and in vitro transfection efficiency of lipoplexes were investigated. In general, higher serum
concentration destabilized, and increasing molar charge ratio of DOTAP to negatively charged phosphates in the DNA (DOTAP+/DNA)
stabilized lipoplexes in serum as assessed by the criteria used in this study. The increase of cholesterol content led to increased serum
stability, and DOTAP:Chol (mol/mol 1:4)/DNA lipoplex with DOTAP+/DNA ratio 4 was the most serum stable formulation of all the
formulations examined, and maintained lipid–DNA interactions, did not aggregate and exhibited high in vitro transfection efficiency in 50%
(v/v) serum. The increased stability of this formulation could not be explained by the decreased charge density of the lipid component.
Furthermore, no single parameter examined in the study could be used to consistently predict the in vitro transfection efficiency of lipoplexes
in serum. Surprisingly, no correlation between the maintenance of supercoiled DNA content and in vitro transfection efficiency was found in
the study.
D 2004 Elsevier B.V. All rights reserved.Keywords: Cationic lipid; Cholesterol; Serum stability; Charge density; Gene delivery
1. Introduction new formulations of existing cationic lipids [9,15,16], and theCationic liposomes have become widely used as nonviral
gene transfer reagents for both in vivo and in vitro applica-
tions [1–3]. However, one drawback of liposome-mediated
gene delivery is that the presence of serum greatly lowers
transfection efficiency [4–10]. Thus, there is an intense effort
to develop cationic lipid/DNA complexes (lipoplexes) that
efficiently transfer genes in the presence of serum. The effort
to improve the activity of cationic liposomes includes the
synthesis of new cationic lipids [11–14], development of0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2004.03.004
Abbreviations: FRET, fluorescence resonance energy transfer; DOTAP,
N-(1-(2,3-dioleoyloxy)propyl)-N,N,N-trimethylammonium chloride;
DOPE, 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine; POPC, 1-
palmitoyl-2-oleoyl-sn-glycerophosphocholine; NBD-PE, 1,2-dipalmitoyl-
sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl);
Chol, cholesterol; DOTAP+/DNA, molar charge ratio of DOTAP to
negatively charged phosphates in the DNA
* Corresponding author. Tel.: +1-303-315-0359; fax: +1-303-315-
6281.
E-mail address: ye.zhang@uchsc.edu (Y. Zhang).addition of a third component such as a polycation or cationic
peptide [17–20]. To date, most investigations of serum
stability have been conducted in low serum concentrations
(e.g., 10–30%) which do not accurately reflect the in vivo
situation [9,12,13,15,19,20]. Among the barriers to transfec-
tion, serum has been reported to exert its inhibitory effect by
binding serum proteins to cationic lipid/DNA complexes,
which leads to structural reorganization, aggregation and/or
dissociation of the complexes [8,10,21,22]. Aggregation
results in rapid clearance and increased toxicity of lipoplexes,
and reduced binding of lipoplexes to cells [6,9,23,24].
Dissociation can result in DNA degradation by serum
nucleases, and decreased amounts of lipoplexes associated
with the target cells. To overcome these barriers, it would be
advantageous to design cationic lipid/DNA formulations that
remain associated as a complex, retain their original particle
size, protect DNA from nucleases, and efficiently transfect
cells in the presence of physiological serum levels.
Previous studies have found that in vivo transfection
efficiency is increased when cholesterol is included in the
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the mechanism responsible for this effect has yet to be fully
elucidated. In an attempt to explain the greater stability upon
incorporation of cholesterol, Crook et al. [22] suggested that
serum stability may be determined by the charge density of
the lipid component. In this context, we interpret ‘‘charge
density’’ to refer to the number of positive charges distrib-
uted throughout the volume of the lipid component, i.e., the
lipid charge density. To test the role of lipid charge density
in serum stability, we maintained constant quantities of the
cationic lipid DOTAP but varied the amounts of cholesterol
within the formulation. Serum effects on physicochemical
and biological characteristics of lipoplexes composed of 1,
2-dioleoyl-3-trimethyammonim propane (DOTAP):choles-
terol (mol/mol 2:1, 1:1, 1:2, and 1:4) were assessed. To
further investigate the effect of lipid charge density, the
stability of different lipid formulations with equivalent
charge densities [e.g. by incorporating POPC (1-palmitoyl-
2-oleoyl-sn-glycerophosphocholine) or DOPE (1,2-dio-
leoyl-sn-glycero-3-phosphatidylethanolamine)] was moni-
tored in serum over 24 h. In monitoring serum ‘‘stability’’,
fluorescence resonance energy transfer (FRET) was used to
assess the association between lipid and DNA in serum [28],
and supercoiled DNA content was evaluated by agarose gel
electrophoresis. Vector aggregation could not be reliably
assessed by dynamic light scattering due to the presence of
serum, so turbidity measurements were employed to mon-
itor this aspect of lipoplex stability. These physicochemical
properties were compared with transfection of mouse endo-
thelial cells to more fully assess effects of serum on rates of
gene delivery.2. Materials and methods
2.1. Materials
Plasmid DNA (5 kb, >90% supercoiled) encoding green
fluorescent protein under control of the cytomegalovirus
promoter (pGreen lantern-1; Gibco-BRL) was propagated
in E. coli and purified by Aldevron Custom Plasmid
Purification (Fargo, ND). It was used for experiments
investigating physicochemical characteristics. Luciferase
plasmid DNA (5.9 kb) was a generous gift from Valentis
Inc. (Burlingame, CA). N-(1-(2,3-Dioleoyloxy)propyl)-
N,N,N-trimethylammonium chloride (DOTAP), 1,2-dio-
leoyl-sn-glycero-3-phosphatidylethanolamine (DOPE), cho-
lesterol, 1-palmitoyl-2-oleoyl-sn-glycerophosphocholine
(POPC) and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanol-
amine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (NBD-PE)
were purchased from Avanti Polar Lipids (Alabaster, AL).
Cy3 Label IT kits used for covalent labeling of plasmid
DNA were acquired from Mirus (Madison, WI). The lucif-
erase assay kit was obtained from Promega (Madison, WI).
Mouse serum was purchased from PanBio (Columbia, MD).
It was filtered with 0.2-Am low protein binding celluloseacetate filter from Fisher Scientific (Pittsburgh, PA) before
use. All chemicals were of reagent grade or higher quality.
2.2. Preparation of labeled DNA
DNA labeling with Cy3 was carried out as previously
described [28]. Briefly, DNA and labeling reagent were
mixed in HEPES buffer (25 mM HEPES, 1 mM EDTA, pH
7.5) and incubated for 1 h at 37 jC. Unreacted labeling
reagent was removed by NaCl/ethanol precipitation. The
labeled DNAwas redissolved in 2.5 mM HEPES buffer and
quantitated by UV absorbance at 260 nm. The fluorescence
of Cy3-DNA was measured and compared to a standard
curve to determine the extent of Cy3-labeling on DNA.
Utilizing this procedure, a Cy3 label concentration of 2.6%
(w/w) of plasmid DNA was obtained, and used in our
experiments.
2.3. Preparation of liposomes
DOTAP, combined with cholesterol, DOPE, or POPC in
different mole ratios, was mixed in chloroform. The lipid
mixture was dried under a stream of nitrogen gas and placed
under vacuum (100 mTorr) for 2 h to remove residual
chloroform, and dried lipids were subsequently resuspended
in autoclaved, distilled water. Cationic liposomes were
prepared the day before the experiment, stored overnight
at 4 jC, and sonicated immediately before use. For the
labeled lipid preparations, different lipid compositions in
chloroform were mixed with NBD-PE, to achieve a final
concentration of 2.6 mol% labeled lipid as previously
described [28].
2.4. Preparation of lipoplexes
Lipoplexes with different DOTAP+/DNA charge ratios
(0.5, 1, 2 and 4) were prepared by mixing different
volumes of our stock lipid suspension with DNA. Lip-
oplexes were incubated for 1 h at room temperature; our
previous work has demonstrated that this incubation period
is necessary for these lipoplexes to form stable complexes
[28]. The lipoplex suspension was subsequently diluted in
buffer (2.5 mM Tris–HCl, pH 7.5) with different amounts
of serum to achieve final serum concentrations of 0%,
10%, 30%, and 50% (v/v). It should be noted that there is
some discrepancy in the literature regarding how serum
concentrations are reported. While we have chosen to
report serum levels as volume-to-volume percentages rang-
ing from 0% to 50%, some previous investigators consider
a 1:1 (v/v) mixture of serum and buffer to be 100% serum.
This twofold discrepancy likely stems from the fact that
blood is approximately half serum by volume, and there-
fore a solution prepared by diluting serum with an equal
volume of buffer represents ‘‘full strength’’ serum. Al-
though we appreciate this argument, we feel that volume-
to-volume percentages are the most accurate way to report
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a concentration that approximates physiological serum
concentrations.
2.5. FRET assay
FRET was employed to monitor the extent of dissocia-
tion of DNA from lipids that occurs in the presence of
serum. FRET was determined by monitoring the decrease in
fluorescence of NBD-PE (donor) in the presence of the Cy3-
DNA (acceptor) on a SpectraMax microplate fluorescence
reader (Molecular Devices, Sunnyvale, CA) as previously
described [28]. Data were reported as efficiency of FRET,
which is calculated according to the equation:
E ¼ 1 FDA=FD
where FDA and FD are the fluorescence intensity of the
NBD-PE (excitation at 463 nm and emission at 528 nm with
4-nm excitation and emission slits) in the presence of Cy3-
DNA and unlabeled DNA, respectively. The final DNA
concentration in the lipoplexes was held constant at 1.67 Ag/Fig. 1. The effect of serum concentration (0–50%) on the relative FRET efficie
DNA charge ratios. Panel A, charge ratio 0.5; panel B, charge ratio 1; panel C,
circle, 10% serum; closed triangle, 30% serum; open triangle, 50% serum. Symbml (5 AM DNA phosphate) in all the experiments. The
samples were incubated at 37 jC and analyzed at 2 min, 5
min, 30 min, 1 h, 4 h, 6 h and 24 h. The FRET efficiency of
time zero lipoplexes in Tris buffer served as a reference. The
relative FRET efficiency was determined by dividing the
sample FRET efficiency by the FRET efficiency of reference
samples.
2.6. Turbidity determination
The absorbance of complexes in the absence and presence
of different serum concentrations (0–50% v/v) was mea-
sured at 500 nm with a corresponding amount of serum alone
as a reference. Lipoplexes were formed with 2 mg/ml lip-
osomes and 668 Ag/ml DNA solutions, and the final DNA
concentration was 8.35 Ag/ml. The samples were incubated
at 37 jC and analyzed at 2 min, 5 min, 30 min, 1 h, 4 h, 6
h and 24 h. Relative turbidity was determined by dividing the
sample turbidity by the turbidity of time zero lipoplexes
incubated in Tris buffer. Therefore, a relative turbidity value
of 1 indicates that the turbidity from lipoplexes incubated inncy of DOTAP:Chol (mol/mol 1:1)/DNA lipoplexes at different DOTAP+/
charge ratio 2; and panel D, charge ratio 4. Closed circle, no serum; open
ols and error bars represent the meanF 1 S.D. of triplicate samples.
Y. Zhang, T.J. Anchordoquy / Biochimica et146serum is equivalent to the turbidity arising from the identical
lipoplex formulation incubated in buffer.
2.7. Agarose gel electrophoresis and quantification of DNA
integrity
The vectors possessing different lipid compositions were
incubated at 37 jC, and aliquots containing 800-ng DNA
were collected at 5 min, 30 min, 1 h, 4 h, and 24 h. Samples
were subjected to a standard phenol–chloroform extraction
procedure to remove lipids and serum proteins [29]. The
amounts of supercoiled plasmid were detected on a 0.8%
agarose gel to monitor DNA degradation due to nucleases in
serum. DNA was visualized under UV light by ethidium
bromide staining [29]. The fluorescent staining was then
quantified by fluorometric image analysis with a Fluor-S
MultiImager and Quantity OneR software (Biorad, Hercules,
CA).Fig. 2. The effect of serum concentration (0–50%) on the relative turbidity of DOT
ratios. Panel A, charge ratio 0.5; panel B, charge ratio 1; panel C, charge ratio 2; an
closed triangle, 30% serum; open triangle, 50% serum. Symbols and error bars r2.8. In vitro transfection assay
Murine brain endothelial cells (middle T antigen trans-
formed; bEnd.3) were obtained from American Type Cul-
ture Collection (Rockville, MD). Cells were incubated at 37
jC in a humidified atmosphere containing 5% CO2. Cells
were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum
(FBS), 50 units/ml penicillin G, and 50 Ag/ml streptomycin
sulfate, and are propagated by reseeding at 1–3 105 cells/
100-mm dish every 2–3 days. For in vitro transfection,
cultures were freshly seeded at 2500 cells/well in 96-well
plates 24 h before transfection. Lipoplexes (20 Al) contain-
ing 0.2-Ag DNA were incubated at room temperature for 1
h and then preincubated in the presence of different con-
centrations of mouse serum for 5 min, 30 min, 1 h, 4 h and
24 h before being applied to wells containing freshly
washed cells. The cells were incubated with lipoplexes for
Biophysica Acta 1663 (2004) 143–157AP:Chol (mol/mol 1:1)/DNA lipoplexes at different DOTAP+/DNA charge
d panel D, charge ratio 4. Closed circle, no serum; open circle, 10% serum;
epresent the meanF 1 S.D. of triplicate samples.
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containing FBS and antibiotics. Forty hours after transfec-
tion, the culture medium was discarded, and the cells were
washed twice with 100-Al phosphate buffered saline (PBS)
and then lysed with 80 Al of lysis buffer (Promega). Twenty
microliters of cell lysis solution was used to assay for
luciferase expression using the luciferase assay kit (Prom-
ega), according to the manufacturer’s protocol. The signal
was quantified using a Monolight 2010 Luminometer (An-
alytical Luminescence Laboratory, Ann Arbor, MI). Protein
contents were determined with a Bio-Rad protein assay kit
(Hercules, CA) according to the manufacturer’s instructions.
The absorbance was measured at 550 nm using a THER-
MOmax microplate reader (Molecular Devices).
2.9. Dynamic light scattering and zeta potential analysis
Samples containing 4-Ag plasmid were diluted to a final
volume of 500 ml with 2.5 mM Tris–HCl pH 7.5. Diluted
samples were transferred to a cuvette for dynamic lightFig. 3. The effect of serum concentration (0–50%) on the supercoiled DNA con
DNA charge ratios. Panel A, charge ratio 0.5; panel B, charge ratio 1; panel C,
circle, 10% serum; closed triangle, 30% serum; open triangle, 50% serum. Symbscattering analysis on a Nicomp 380 Zeta Potential/Particle
Sizer (Particle Sizing Systems, Santa Barbara, CA). Channel
width was set automatically based on the rate of fluctuation
of scattered light intensity and 1106 counts were accu-
mulated at 25 jC from triplicate samples representing each
formulation. Volume-weighted Gaussian size distribution
was fit to the autocorrelation functions and particle size
values obtained as previously described [30]. Samples were
then diluted to a final KCl concentration of 1 mM, and
subjected to an electric field in a Nicomp 380 Zeta Potential/
Particle Sizer for zeta potential determination.3. Results
3.1. Effect of serum concentration and DOTAP+/DNA
ratio on lipid–DNA interactions within lipoplexes
To investigate the effect of serum on lipid–DNA inter-
actions, FRET efficiency was monitored using DOTAP:tent of DOTAP:Chol (mol/mol 1:1)/DNA lipoplexes at different DOTAP+/
charge ratio 2; and panel D, charge ratio 4. Closed circle, no serum; open
ols and error bars represent the meanF 1 S.D. of triplicate samples.
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DNA ratios (0.5, 1, 2 and 4) and incubated at 37 jC in
different concentrations of mouse serum (Fig. 1). For
DOTAP-Chol/DNA lipoplexes in Tris buffer alone, at all
DOTAP+/DNA ratios examined, FRET efficiency varied in
the first hour, then remained stable for 24 h, consistent with
previous results [28]. However, the presence of serum
caused a decrease of FRET efficiency, indicating that
dissociation of lipid from DNA occurs under these con-
ditions. Furthermore, the low FRET efficiency at our initial
timepoint (2 min) indicates that much of the observed
dissociation occurs immediately upon dilution of complexes
into serum. The effect of serum components in weakening
lipid–DNA interactions is more pronounced at higher serum
concentrations, but is attenuated at higher charge ratios (Fig.
1). In the presence of serum, FRET efficiencies decreased
over the time course of incubation at 37 jC. At charge ratio
0.5, the relative FRET efficiency was 0.787F 0.043 at 2
min and 0.447F 0.043 after 24 h in 10% mouse serum. In
50% serum, the relative FRET efficiency decreased to
0.340F 0.191 at 2 min and 0.043F 0.085 after 24 h (Fig.
1A). The very low FRET efficiency after 24 h suggestsFig. 4. The effect of serum concentration (0–50%) on the in vitro transfection effic
DNA charge ratios. Panel A, charge ratio 0.5; panel B, charge ratio 1; panel C,
circle, 10% serum; closed triangle, 30% serum; open triangle, 50% serum. Symbthat lipoplexes are almost completely dissociated under
these conditions. At charge ratios 1, 2 and 4, the same
trends with serum concentration and incubation time were
observed. However, the dissociating effects of serum were
clearly diminished at higher charge ratios, and this effect
persisted throughout the 24-h incubation. For example, the
relative FRET efficiencies of samples incubated in 50%
serum were 0.185F 0.111 at charge ratio 1, 0.282F 0.114
at charge ratio 2, and 0.545F 0.1136 at charge ratio 4 after
a 24-h incubation (Fig. 1).
3.2. Effect of serum concentration and DOTAP+/DNA
charge ratio on turbidity
To investigate the effect of serum on lipoplex aggrega-
tion, turbidity was monitored using DOTAP:Chol (mol/mol
1:1)/DNA lipoplexes prepared at different DOTAP+/DNA
ratios (0.5, 1, 2 and 4) and incubated at 37 jC in different
concentrations of mouse serum (Fig. 2). For DOTAP-Chol/
DNA lipoplexes in Tris buffer alone, an increase in turbidity
was observed during incubation at 37 jC, indicating a
progressive aggregation with time. Turbidity increased sig-iency of DOTAP:Chol (mol/mol 1:1)/DNA lipoplexes at different DOTAP+/
charge ratio 2; and panel D, charge ratio 4. Closed circle, no serum; open
ols and error bars represent the meanF 1 S.D. of triplicate samples.
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suggesting that aggregation is enhanced in the presence of
serum. Similar to the rapid dissociation observed in the
FRET experiments (Fig. 1), much of the aggregation occurs
within 2 min of exposure to serum (Fig. 2). Surprisingly, the
presence of 30% serum caused more aggregation than other
serum concentrations for lipoplexes at charge ratio 1 (Fig.
2B), and no consistent difference between aggregation in
30% and 50% serum was found at charge ratios 0.5 (Fig.
2A) and 4 (Fig. 2D). A similar effect at intermediate serum
concentrations has been observed in other studies [31], but
we did not observe this effect at charge ratio 2 (Fig. 2C). In
general, turbidity tended to increase with serum concentra-
tion and time, reflecting trends similar to that seen with
FRET. The clear exception to this general trend was
observed at DOTAP+/DNA of 1, where aggregation
appeared to be completed within 2 min, and relatively
constant turbidity was observed over time (Fig. 2B).
3.3. Effect of serum concentration and DOTAP+/DNA
charge ratio on DNA degradation
The presence of nuclease in the serum can degrade DNA,
resulting in a loss of supercoil content and biological activity
[32]. Not surprisingly, a progressive decrease in supercoil
content was observed at higher serum concentrations regard-
less of charge ratio (Fig. 3). For DOTAP:Chol (mol/mol 1:1)/
DNA lipoplexes at charge ratio 0.5, only 54F 2%, 28F 3%,
and 20F 3% supercoiled DNA remained after 5 min in 10%,
30%, and 50% (v/v) serum, respectively (Fig. 3A). Further-
more, loss of supercoil was enhanced at longer incubationTable 1
(a) Particle diameter (nm) of lipoplexes with different helper lipid compositions a
buffer pH 7.5. The mean and the standard deviation of triplicate samples are sho
+/ 0.5 +/ 1
DOTAP:Chol (2:1) 251.0F 94.7 761.2F
DOTAP:Chol (1:1) 192.4F 11.6 1480.0F
DOTAP:Chol (1:2) 127.3F 18.5 642.9F
DOTAP:Chol (1:4) 113.2F 16.8 469.6F
DOTAP:Chol (1:8) 657.8F 193.7 322.4F
DOTAP:Chol (1:16) 598.5F 56.0 405.4F
DOTAP:Chol:POPC (1:1:0.75) 182.0F 9.4 2088.3F
DOTAP:Chol:DOPE (1:1:0.75) 92.0F 9.8 285.2F
(b) Zeta potential (mV) of lipoplexes with different helper lipid compositions at dif
pH 7.5. The mean and the standard deviation of triplicate samples are shown.
+/ 0.5 +/ 1
DOTAP:Chol (2:1)  24.1F 0.4  21.9F
DOTAP:Chol (1:1)  21.7F 3.4  27.8F
DOTAP:Chol (1:2)  33.4F 2.7  36.3F
DOTAP:Chol (1:4)  37.8F 2.1  41.8F
DOTAP:Chol (1:8)  33.1F 0.5  34.1F
DOTAP:Chol (1:16)  34.9F 2.8  34.6F
DOTAP:Chol:POPC (1:1:0.75)  26.5F 3.2  29.3F
DOTAP:Chol:DOPE (1:1:0.75)  27.0F 6.4  28.8Ftimes. Consistent with the FRET and turbidity data that
indicated structural perturbations in the presence of serum,
the loss of supercoil content suggests that these structural
changes result in exposure of DNA to serum nucleases. As
seen in the FRET results, the increase of DOTAP+/DNA
ratio resulted in enhanced DNA protection in all the serum
concentrations, presumably due to the greater lipid–DNA
interactions observed in Fig. 1. However, even at charge
ratio 4, only 16F 3% supercoiled DNA remained after a 24-
h incubation in 50% serum (Fig. 3D).
3.4. Effect of serum concentration and DOTAP+/DNA
ratio on in vitro transfection efficiency
At DOTAP+/DNA ratio 0.5, the in vitro transfection
efficiencies of DOTAP:Chol (mol/mol 1:1)/DNA lipoplexes
were relatively low regardless of the presence of serum (Fig.
4A). Furthermore, transfection was virtually eliminated in
these formulations after 24 h (Fig. 4A). Enhanced in vitro
transfection efficiencies were found at higher charge ratios,
and serum concentration and incubation time had much
smaller effects on transfection efficiency in formulations of
DOTAP+/DNA of 1, 2, and 4 (Fig. 4B–D). However, there
was a clear trend of reduced transfection observed at higher
serum concentrations and longer incubation times. Taken
together, the data in Figs. 1–4 indicate enhanced stability at
higher charge ratios. Although transfection remained rela-
tively high at a DOTAP+/DNA of 1, the size of particles is
relatively large even before exposure to serum (Table 1a), so
formulations at charge ratios 2 and 4 were used in further
experiments to investigate the role of charge density. Int different DOTAP +/DNA charge ratios (0.5, 1, 2 and 4) in 2.5 mM Tris
wn.
+/ 2 +/ 4
116.6 216.3F 11.8 153.8F 14.0
197.9 212.5F 8.5 197.8F 41.0
102.2 146.9F 20.9 140.4F 3.7
98.6 260.0F 17.8 120.7F 15.0
11.2 285.8F 79.8 520.6F 18.4
35.3 428.3F 10.6 833.2F 34.3
461.9 447.9F 139.5 405.6F 223.8
7.2 160.9F 37.9 136.5F 24.9
ferent DOTAP +/DNA charge ratios (0.5, 1, 2 and 4) in 2.5 mM Tris buffer
+/ 2 +/ 4
1.9 26.7F 5.1 27.8F 4.1
5.7 35.3F 1.4 32.9F 1.5
0.3 33.6F 4.1 43.2F 5.7
1.2 45.7F 0.3 51.7F 1.6
2.0 28.9F 1.1 47.7F 0.2
1.8 29.7F 2.1 49.5F 3.6
1.3 19.5F 1.5 41.0F 3.9
3.8 35.1F1.4 37.9F 4.5
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tion for in vivo applications, we utilized these conditions to
compare the stability of different lipoplex formulations in
subsequent experiments.
3.5. Effect of lipid charge density on lipoplex serum stability
at DOTAP+/DNA charge ratio 2 in 50% serum
In the experiments depicted in Figs. 1–4, the DOTAP:
Chol ratio was held constant at 1. Although the DOTAP+/
DNA charge ratio was altered in those experiments, the
charge density of the lipid component remained constant.
The data shown in Fig. 5 represent experiments where the
DOTAP:Chol ratio was varied while maintaining DOTAP+/
DNA at 2, thereby altering the charge density of the lipid
component. As shown in Fig. 5A, all the formulations
exhibited dramatic reductions in FRET within the first hour,
indicating a rapid perturbation of lipoplex structure in 50%
(v/v) serum. This rapid initial reduction in FRET wasFig. 5. The effect of lipid charge density on the stability of DOTAP:Chol/DNA lip
FRET efficiency; panel B, relative turbidity; panel C, supercoiled DNA content; an
mol 2:1); open circle, DOTAP:Chol (mol/mol 1:1); closed triangle, DOTAP:Chol (
bars represent the meanF 1 S.D. of triplicate samples.followed by a more gradual dissociation, and the relative
FRET efficiencies ranged from 0.15 to 0.3 after a 24-
h incubation (Fig. 5A). No major differences in relative
FRET efficiencies were detected in DOTAP:Chol/DNA lip-
oplexes containing different mole concentrations of choles-
terol. However, formulations showed dramatic differences
in their tendency to aggregate in 50% serum, as indicated by
changes in turbidity (Fig. 5B). A decrease in DOTAP:Chol
mole ratio from 1:1 to 1:2 to 1:4 resulted in a progressive
decrease in lipoplex aggregation. This apparent trend was
not followed by the DOTAP:Chol 2:1 formulation which
demonstrated turbidity changes that were intermediate to the
1:1 and 1:2 formulations. Surprisingly, no aggregation was
detected in the DOTAP:Chol 1:4 formulation even after 24
h in 50% serum (Fig. 5B).
The supercoiled DNA content of all formulations de-
creased rapidly within the first hour, although the 1:1 and
1:2 formulations clearly showed greater abilities to protect
DNA at early timepoints (Fig. 5C). After a 24-h incubation,oplexes in 50% serum at DOTAP+/DNA charge ratio 2. Panel A, relative
d panel D, in vitro transfection efficiency. Closed circle, DOTAP:Chol (mol/
mol/mol 1:2); open triangle, DOTAP:Chol (mol/mol 1:4). Symbols and error
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11% of initial levels. In contrast to supercoil content, in
vitro transfection efficiency was largely independent of
DOTAP:Chol ratio and remained relatively constant over
24 h (Fig. 5D).
3.6. Effect of lipid charge density on lipoplex serum stability
at DOTAP+/DNA ratio 4 in 50% serum
Similar to that seen at charge ratio 2, FRET efficiencies
decreased in the first hour, then remained relatively stable up
to 24 h (Fig. 6A). The relative FRET efficiencies were higher
in all DOTAP:Chol/DNA lipoplexes at charge ratio 4 as
compared to those at charge ratio 2 (compare Figs. 5A and
6A), suggesting that the higher charge ratio enhanced the
association between lipid and DNA. After 24 h, the relative
FRET efficiencies were retained at values of approximately
0.5 for DOTAP:Chol 1:1 and 1:4, suggesting that these
vectors did not undergo the extensive dissociation that was
generally observed at lower charge ratios (Fig. 6A). DespiteFig. 6. The effect of lipid charge density on the stability of DOTAP:Chol/DNA lip
FRET efficiency; panel B, relative turbidity; panel C, supercoiled DNA content; an
mol 2:1); open circle, DOTAP:Chol (mol/mol 1:1); closed triangle, DOTAP:Chol (m
bars represent the meanF 1 S.D. of triplicate samples.the enhanced associations indicated by FRET, the turbidity
and DNA degradation results were similar to those observed
at charge ratio 2 (compare Figs. 5B–C and 6B–C). More
specifically, DOTAP:Chol 1:4 was able to resist aggregation
in 50% serum (Fig. 6B), but all formulations experienced a
dramatic reduction in supercoiled DNA content that was
further reduced below 30% after 24 h (Fig. 6C). In contrast to
that observed at DOTAP+/DNA 2, the formulations dis-
played sharp differences in transfection efficiency, and were
comparatively low and variable with incubation time (Fig.
6D). However, the DOTAP:Chol 1:4 formulation exhibited
high and stable transfection efficiency over the time course
of this experiment (Fig. 6D). Furthermore, the transfection
efficiency of this formulation in 50% serum (9.1107 RLU/
mg protein) was greater than that observed in the absence of
serum (1.3 107 RLU/mg protein) after 24 h. In general, we
conclude that there is no consistent correlation of lipid–
DNA interactions, aggregation, nuclease protection or in
vitro transfection efficiency with lipid charge density at
DOTAP+/DNA 2 or 4.oplexes in 50% serum at DOTAP+/DNA charge ratio 4. Panel A, relative
d panel D, in vitro transfection efficiency. Closed circle, DOTAP:Chol (mol/
ol/mol 1:2); open triangle, DOTAP:Chol (mol/mol 1:4). Symbols and error
a et Biophysica Acta 1663 (2004) 143–1573.7. Effect of lipid composition on lipoplex serum stability
The results described above do not show a strong
correlation between enhanced serum stability and reduced
lipid charge density. It follows that some of the improved
characteristics observed with high cholesterol formulations
might be specifically due to the increased cholesterol
content rather than a reduction in charge density per se.
To investigate this hypothesis, the serum stability of lip-
oplexes with the same charge density but different helper
lipid composition was assessed. Previous studies have
shown that mixing DNA with cationic liposomes can lead
to lipoplexes with either a lamellar structure or a columnar
inverted hexagonal lattice [33]. Thus, a lipid that promotes
lamellar structure (POPC) and a lipid that facilitates
hexagonal phase formation (DOPE) were selected for use
as helper lipids in combination with cholesterol. Data from
X-ray diffraction studies have reported that the molecular
area of PC is 62.7 A˚2, cholesterol is 35 A˚2, and condensed
PC in the presence of cholesterol is 46.7 A˚2 [34,35]. Thus,
Y. Zhang, T.J. Anchordoquy / Biochimic152Fig. 7. The effect of lipid composition on the stability of lipoplexes in 50% seru
relative turbidity; panel C, supercoiled DNA content; and panel D, in vitro trans
DOTAP:Chol:POPC (mol/mol/mol 1:1:0.75); closed triangle, DOTAP:Chol:DOP
S.D. of triplicate samples.one cholesterol molecule occupies approximately the same
area as 0.75 PC molecules when these lipids are combined.
To obtain the same charge density as DOTAP:Chol (mol/
mol 1:2), DOTAP:Chol:POPC (mol/mol/mol 1:1:0.75) was
used as a model lipid formulation. These formulations
were compared with DOTAP:Chol:DOPE (mol/mol/mol
1:1:0.75), under the assumption that the volume occupied
by DOPE in the bilayer is similar to that of POPC. At
DOTAP+/DNA ratio 2, no difference in FRET efficiency
was observed between DOTAP:Chol (1:2) and POPC
containing lipoplexes (Fig. 7A). Surprisingly, the inclusion
of DOPE resulted in no FRET, suggesting a rapid disin-
tegration of these lipoplexes in 50% serum (Fig. 7A),
which was confirmed by turbidity data (Fig. 7B). The
relative FRET efficiency for DOPE-containing lipoplexes
below zero can be understood in the context of the FRET
efficiency calculation: E = 1FDA/FD. The values of FDA
(f 135 at 24 h) and FD (f 130 at 24 h) in 50% serum
were very close due to the dissociation of DNA and
DOTAP:Chol:DOPE. This small difference ( < 4%) result-m at DOTAP+/DNA ratio 2. Panel A, relative FRET efficiency; panel B,
fection efficiency. Closed circle, DOTAP:Chol (mol/mol 1:2); open circle,
E (mol/mol/mol 1:1:0.75). Symbols and error bars represent the meanF 1
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efficiency after calculation. For reference, the value of FDA
was 90.4 and FD was 102 at time zero in Tris buffer alone
for DOPE containing lipoplexes. Similarly, the turbidity of
DOPE-containing lipoplexes in Tris buffer alone at time
zero was 0.445 and it remained constant for 24 h (data not
shown). As mentioned above, the relative turbidity of
DOPE-containing lipoplexes less than 1 (Fig. 7B) can only
be explained by the dissociation of lipoplexes in the
presence of 50% serum. POPC-containing lipoplexes rap-
idly aggregated and generated high turbidity in 50% serum
(Fig. 7B), consistent with the loss of biological activity
(Fig. 7D). The increase of DOTAP+/DNA ratio from 2 to
4 resulted in stronger associations between lipid and
DNA, which was reflected by the enhanced FRET
efficiencies in all formulations (compare Figs. 7A and
8A). However, even at this higher charge ratio, DOPE
containing lipoplexes dissociated and lost transfection
activity after 24 h in 50% serum (Figs. 8A and 8D).Fig. 8. The effect of lipid composition on the stability of lipoplexes in 50% seru
relative turbidity; panel C, supercoiled DNA content; and panel D, in vitro trans
DOTAP:Chol:POPC (mol/mol/mol 1:1:0.75); closed triangle, DOTAP:Chol:DOP
S.D. of triplicate samples.POPC containing lipoplexes exhibited high turbidity and
low transfection similar to that observed at DOTAP+/
DNA 2. In all formulations at both charge ratios, the
protection of DNA from serum nucleases was minimal
after the first few hours, although slightly higher super-
coil contents were seen at DOTAP+/DNA 4 as compared
to 2 (Figs. 7C and 8C).4. Discussion
Detrimental interaction with serum components is one of
the major barriers which intravenous nonviral gene delivery
has to overcome. A previous study reported that the
immediate effect of serum on cationic lipoplexes was
aggregation, and that further interactions with serum led
to lipoplex dissociation, DNA release and degradation [10].
The inclusion of cholesterol in lipoplex formulations has
been shown to result in a slower dissociation in serum,m at DOTAP+/DNA ratio 4. Panel A, relative FRET efficiency; panel B,
fection efficiency. Closed circle, DOTAP:Chol (mol/mol 1:2); open circle,
E (mol/mol/mol 1:1:0.75). Symbols and error bars represent the meanF 1
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observed with cholesterol-containing lipoplexes [10,18,
21,22,25–27]. Similarly, Crook et al. [22] reported that
cholesterol-containing lipoplexes maintained their ability to
bind to cells in the presence of serum, and suggested that
this effect was due to the decreased lipid charge density in
lipoplexes incorporating cholesterol. More recently, Lin et
al. [36] have suggested that the lipid charge density is the
key universal parameter that determines transfection, al-
though these authors were careful not to extend their
conclusions to experiments conducted in the presence of
serum. The goal of our study was to investigate the role of
charge density in determining serum stability. In trying to
define ‘‘stability’’ in this context, we felt that the degree of
lipoplex dissociation, aggregation, and the ability to protect
plasmids from serum nucleases were the critical parameters
that would likely be important for maintaining transfection
rates. Accordingly, we directly monitored lipid–DNA inter-
actions with FRET, assessed the extent of aggregation in
serum with turbidity, determined changes in supercoil
content after exposure to serum, and evaluated transfection
in mouse endothelial cells. FRET had been carried out
under physiological conditions due to its lower sensitivity
to coexisting components [10,20,37]. However, in the
previous FRET studies, either FRET between lipid mole-
cules [10,20] or FRET between DNA molecules [37] was
used to reflect the interactions between cationic vectors and
DNA indirectly.
Although it is widely recognized that the presence of
serum can dramatically alter the performance of nonviral
vectors, previous studies on serum stability have tended to
conduct experiments in fetal bovine serum and/or at low
serum concentrations that mimic cell culture conditions
[9,12,13,15,19,20]. However, the goal of many studies is
to develop delivery systems that can be utilized in vivo, and
therefore it behooves researchers to utilize serum conditions
that more accurately mimic physiological conditions. In this
context, it is important to recognize that previous studies
have documented distinct differences between various sera,
and shown that mouse serum more accurately mimics
human serum conditions [10,38]. Furthermore, it should
not be surprising that vector stability is dependent on serum
concentration, and it was recently suggested that serum
stability studies should be performed at physiological serum
concentrations (c 50% v/v) in order to approximate in
vivo conditions [31]. Our results are consistent with this
suggestion, and demonstrate that higher serum concentra-
tions have progressively greater negative impacts on lip-
oplex performance (Figs. 1–4). Also consistent with
previous reports, our data show that the stability of lip-
oplexes in serum can be dramatically improved by utilizing
higher +/ charge ratios [9,26]. Thus, in investigating the
role of lipid charge density in serum stability, we employed
lipoplexes at high DOTAP+/DNA charge ratios (2 and 4)
in experiments conducted in physiological concentrations of
mouse serum.To test the role of lipid charge density in serum stability,
increasing amounts of cholesterol were formulated with
DOTAP at a constant DOTAP+/DNA charge ratio. Our
results do not show any consistent correlations of changes in
lipid–DNA interactions, aggregation, nuclease resistance,
or transfection with altered lipid charge density of the
formulations. However, we did observe a progressive de-
crease in serum-induced aggregation as cholesterol content
was increased from 50% (DOTAP:Chol 1:1) to 80%
(DOTAP:Chol 1:4) at both charge ratios 2 and 4 (Figs. 5B
and 6B), but this trend was not followed by the high charge
density formulation with the lowest cholesterol content
(DOTAP:Chol 2:1). Although lower lipid charge densities
did not provide enhanced stability in our experiments, the
lowest charge density formulation with high cholesterol
content did exhibit remarkable stability in terms of main-
taining particle size and transfection efficiency in 50%
serum. This effect was especially striking at charge ratio 4
where even the FRET data indicate that approximately half
of the lipid–DNA associations were maintained after 24
h (Fig. 6A). To test if higher cholesterol contents would lead
to further improvements in serum stability, DOTAP:Chol
(mol/mol 1:8) and DOTAP:Chol (mol/mol 1:16) were
prepared. Unfortunately, large particle sizes were measured
for liposomes alone (580.2F 49.1 and 919.7F 39.7 nm for
DOTAP:Chol 1:8 and 1:16 liposomes, respectively), and
lipoplexes (>500 nm) at charge ratio 4 (Table 1), indicating
that these formulations would not be suitable for in vivo
administration. Also, the in vitro transfection efficiency of
these formulations in 50% serum proved to be approximate-
ly 1/10 (DOTAP:Chol mol/mol 1:8) and 1/15 (DOTAP:Chol
mol/mol 1:16) of that in DOTAP:Chol (mol/mol 1:4) for-
mulations (data not shown). Thus, additional serum stability
studies were not conducted with these formulations.
Considering the trend noted above of less aggregation at
lower lipid charge densities, it is important to recognize that
the lipid charge densities were reduced in our formulations
by increasing the relative amount of cholesterol. Thus, the
enhanced resistance to aggregation could be due to either
decreased lipid charge density or the increased cholesterol
content utilized in these formulations. Accordingly, addi-
tional experiments were conducted using formulations in-
corporating different neutral lipids at a constant lipid charge
density. Our results demonstrate that lipoplexes possessing
equivalent lipid charge densities exhibit very different
serum stabilities as determined by all of our criteria (Figs.
7 and 8). While differences in formulations containing
lipids that stabilize a lamellar structure (e.g., POPC) versus
lipids that promote hexagonal phase formation (e.g., DOPE)
might be expected [39], neither of these formulations
displayed characteristics similar to that seen with the
DOTAP:Chol lipoplexes when incubated in 50% serum.
We conclude from these experiments that serum stability is
not governed simply by lipid charge density, and that
cholesterol must possess properties that allow lipoplexes
to resist aggregation and maintain transfection in serum. In
Y. Zhang, T.J. Anchordoquy / Biochimica et Biophysica Acta 1663 (2004) 143–157 155similar studies with liposomes, the presence of at least 25
mol% cholesterol was found to be required to preserve
serum stability [22,40].
With regards to the mechanism by which cholesterol
endows lipoplexes with enhanced serum stability, we can
only speculate that increasing the amount of cholesterol
causes a resistance to perturbations induced by the binding
of serum proteins. A similar mechanism was proposed by
Templeton et al. [25] who concluded that cholesterol
enhances bilayer stability that results in greater resistance
to mechanical breakage upon serum adsorption. It is impor-
tant to point out that the decreased FRET observed in all
formulations exposed to serum clearly demonstrates that
perturbations of the lipoplex structure have occurred even in
formulations where particle size and transfection are main-
tained. Furthermore, the highly positive zeta potentials for
each of the formulations at DOTAP+/DNA 4 were reduced
to slightly negative values ( 2 to  8 mV) upon exposure
to serum (data not shown). These results indicate that the
enhanced serum stability observed for the DOTAP:Chol
(mol/mol 1:4)/DNA lipoplexes was not due to diminished
protein binding [22], but to the ability of this formulation to
withstand the detrimental effects of such binding. It is
interesting to note that studies have shown that cholesterol
contents greater than approximately 30% (mol/mol) result in
a phase separated system in the neutral vesicle bilayer [34].
Although the complexes formed between DNA and cationic
lipids are very different from conventional liposomes,
cholesterol interacted with cationic lipids in much the same
way as it did with other phospholipids [41]. Thus, our
DOTAP:Chol formulations (1:1, 1:2, and 1:4) possess an
increasing amount of phase separated cholesterol that cor-
relates with the enhanced resistance to serum by protecting
lipoplexes against mechanical breakage or aggregation upon
adsorption of serum components [25,42]. In addition, the
fact that the DOTAP:Chol 2:1 formulation did not follow
the general trend of reduced aggregation with increased
cholesterol content may be because this lipoplex does not
possess a substantial amount of phase-separated cholesterol.
Furthermore, it is unlikely that the formulations incorporat-
ing POPC or DOPE in addition to cholesterol (Figs. 7 and 8)
are phase-separated, and this may contribute to the poor
stability observed with these lipoplexes. Alternatively, the
increased amounts of cholesterol may further promote
hexagonal phase formation upon binding to the endosomal
membrane [43,44], facilitate DNA release into cytoplasm
and lead to improved transfection efficiency.
We consistently observe no correlation between the loss
of supercoil content and transfection, as suggested by other
studies [45,46]. In fact, even our most stable formulation
lost approximately 70% of its original supercoil content
within 2 min of serum exposure despite maintaining trans-
fection efficiency (Figs. 6C and 6D). However, it should be
noted that this formulation retained approximately 20% of
its initial supercoil content even after 24 h in serum. Thus, it
could be argued that it is the intact DNA that is responsiblefor the observed transfection. According to this argument,
only a fraction of the lipoplexes in the heterogeneous
particle population are responsible for transfection, and
these ‘‘active’’ vectors are assembled in a structure that
protects DNA from serum nucleases [20,26]. Alternatively,
since the open circle form of DNA is also capable of
transfection [47,48], it may be that the loss of supercoil
content per se does not accurately reflect the capacity of
lipoplexes to transfect cells.
We wish to point out that only one cationic lipid was
investigated here, but studies have shown that the mem-
brane order promoted by cholesterol is independent of lipid
headgroup structure, charge, or the nature of chain-back-
bone links [42]. Therefore, we assume that the enhancement
of serum stability of DOTAP:Chol resulting from the
inclusion of cholesterol is also applicable to other cationic
liposomes.
In summary, our results are consistent with previous
studies demonstrating that the concentration of serum can
have a tremendous effect on the observed ‘‘stability’’ as
assessed by several parameters. We also observe an in-
creased serum stability at high DOTAP+/DNA ratios, and
this effect was further enhanced at high cholesterol contents.
However, the greater serum stability did not directly corre-
late with decreases in lipid charge density, and appeared to
be related to the use of increasing amounts of cholesterol as
a helper lipid. We speculate that the high cholesterol
contents result in a phase-separated cholesterol domain that
contributes to the observed increase in serum stability.
Finally, our results with DOTAP:Chol (mol/mol 1:4)/DNA
lipoplexes at DOTAP+/DNA 4 indicate that this formula-
tion is surprisingly stable in serum, and future work will
characterize its circulating half-life and ability to transfect
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